Display HSQ1099362FPN

For more detailed information on a particular section refer to the help specific to that section.

Times presented in this website are for Queensland (without daylight saving).

Detailed Help (Clicking detailed help will open a new browser window)
Respiratory System and Allergic Disorders

Issued by Queensland Health Pharmaceuticals Category

Forward Procurement Schedule

Status: Closed
Mega Category: Medical
Number: HSQ1099362FPN
Released: Thu, 19 Jan 2023 at 12:00AM Brisbane, Queensland
Closed: Fri, 10 Feb 2023 at 2:00PM Brisbane, Queensland
Expected ITO Date:
UNSPSC: Drugs and Pharmaceutical Products - (100%)
Region/s: Cairns & Far North Queensland
Mount Isa & North West Region
The Central West
South West & Darling Downs
Townsville
Mackay Whitsunday Region
Rockhampton
Gladstone
Wide Bay Burnett
South East Queensland

Section 1

Tender Overview

Forward Procurement Notification - Upcoming Tender

The purpose of this notice is to inform the market of the upcoming opportunity to tender for the supply of products which fall within the Respiratory System and Allergic Disorders Therapeutic Class. Suppliers of pharmaceutical products will have the opportunity to participate in establishing products under the new Pharmaceutical Standing Offer Arrangement (PHA) No. 109936 with Queensland Health. 

The anticipated date for the release of the next tender is approximately Friday 10th February 2023 via QTenders and will be for products that fall in the Respiratory System and Allergic Disorders therapeutic class and associated subclasses. 

The tender will be in market for an 4 weeks, closing 10th March 2023

Any Suppliers that do not have a PHA are welcome to submit offers.

More about tendering here

Section 2

Still need help? Contact Us


Other Contacts
users Rowan Halberstater
Type Technical
email pharmaceuticals-sps@health.qld.gov.au

Section 3

Here is the detail

If there are no documents listed in this section, please refer to Section 1 Tender Overview.

Documents can not be downloaded once Tender has closed.